Law360 (September 30, 2005, 12:00 AM EDT) -- GlaxoSmithKline will go back to court to defend one of the patents for its anti-nausea drug Zofran, the challenge coming this time from generic drug maker Eon Laboratories.
On August 9,...
Glaxo Sues To Protect Zofran Patent
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
